Literature DB >> 25034414

A review of self-report medication side effect questionnaires for mental health patients.

Deena Ashoorian1, Rowan Davidson2, Daniel Rock3, Sajni Gudka4, Rhonda Clifford4.   

Abstract

Side effects of psychotropic medications are important determinants of adherence to treatment. Discussion between the patient and clinician facilitated through the use of a side effect self-report questionnaire (SRQ) could lead to improved communications and treatment adherence. The aim of this review was to 1) identify all currently available side effect SRQs used in the assessment of mental health patients' subjective experiences, 2) evaluate the characteristics of the studies and 3) assess the psychometric properties of each of the questionnaires. Eight electronic databases were searched for peer-reviewed published articles. Six side effect SRQs were identified. Two independent reviewers assessed the quality of the study designs and psychometric properties of the identified SRQs. All questionnaires consisted of closed questions relating to antipsychotic side effects and completion times ranged from 5 to 20 min. Five questionnaires had undergone some form of psychometric testing, ranging from basic to comprehensive. There is a need in everyday clinical practice for a side effect communication tool applicable to all psychotropic medications, which allows the patient to express their subjective beliefs about their medications. This could provide an important contribution to the working relationship between patients and clinicians leading to informed decision-making and improved adherence.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adverse effect; Antipsychotic; Neuroleptic; Psychotropic; Subjective experience

Mesh:

Substances:

Year:  2014        PMID: 25034414     DOI: 10.1016/j.psychres.2014.05.060

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  Development of the My Medicines and Me (M3Q) side effect questionnaire for mental health patients: a qualitative study.

Authors:  Deena M Ashoorian; Rowan M Davidson; Daniel J T Rock; Liza J Seubert; Rhonda M Clifford
Journal:  Ther Adv Psychopharmacol       Date:  2015-10

2.  What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication.

Authors:  T Wykes; J Evans; C Paton; T R E Barnes; D Taylor; R Bentall; B Dalton; T Ruffell; D Rose; S Vitoratou
Journal:  Psychol Med       Date:  2017-04-19       Impact factor: 7.723

3.  A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting.

Authors:  Clément François; Alice Guiraud-Diawara; Christophe Lançon; Pierre Michel Llorca; Ann Hartry; Lene Hammer-Helmich; Djamel A Zighed; Adrian Tanasescu; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2017-09-13

4.  Nurse-led medicines' monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines.

Authors:  Sue Jordan; Timothy Banner; Marie Gabe-Walters; Jane M Mikhail; Jeff Round; Sherrill Snelgrove; Mel Storey; Douglas Wilson; David Hughes
Journal:  BMJ Open       Date:  2018-09-28       Impact factor: 2.692

Review 5.  Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review.

Authors:  Renly Lim; Lisa Kalisch Ellett; Elizabeth E Roughead; Phaik Yeong Cheah; Nashwa Masnoon
Journal:  Int J Environ Res Public Health       Date:  2021-11-12       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.